Drug Profile
SK 1080
Alternative Names: KR 31080Latest Information Update: 25 Mar 2008
Price :
$50
*
At a glance
- Originator Korea Research Institute of Chemical Technology
- Developer Korea Research Institute of Chemical Technology; SK Pharma
- Class Antihypertensives; Imidazoles; Pyridines; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 14 Jun 2001 No-Development-Reported for Hypertension in South Korea (PO)
- 12 Jun 1998 Preclinical development for Hypertension in South Korea (PO)